In order to further elucidate the relationship between the G2M score and cancer immunity, we further analyzed the association of G2M pathway score with several other scores: interferon (IFN)-γ and tumor infiltrating lymphocyte (TIL) regional fraction, lymphocyte infiltration score, and leukocyte fraction score, which were previously calculated by Thorsson et al. [18]. The gene discussed is IFNG; the disease is cancer.